Hydroxypropyl Methylcellulose for the Treatment of Severe Dry Eye Associated with Sjögren's Syndrome

Ikuko Toda, Naoshi Shinozaki, Kazuo Tsubota

Research output: Contribution to journalArticle

66 Citations (Scopus)

Abstract

Our purpose was to evaluate the efficacy of a new formulation of methylcellulose, preservative-free 0.5% hydroxypropyl methylcellulose (HPMC), for the treatment of dry eye. In the clinical part of our study, two groups of dry-eye patients, those with Sjögren's syndrome (SS) and those without (non-SS), were treated topically with 0.5% HPMC and evaluated for symptoms, ocular surface vital staining, tear breakup time (BUT), and tear evaporation rate from the ocular surface at 40% ambient humidity (TEROS40). In the in vitro part of the study, rose bengal uptake was measured in human conjunctival epithelial cells, which were cultured and incubated with or without 0.5% HPMC. Although symptoms improved in both groups, rose bengal and fluorescein staining and BUT improved significantly only in the SS group. TEROS40 increased for 30 min after instillation of 0.5% HPMC, but not after the use of 0.1% sodium hyaluronate or saline-based artificial tears. Rose bengal uptake by cultured conjunctival epithelial cells was blocked by 0.5% HPMC. These findings suggest that 0.5% HPMC provides long coverage of and protection for the ocular surface. Patients with severe dry eye, such as in SS, are good candidates for this treatment.

Original languageEnglish
Pages (from-to)120-128
Number of pages9
JournalCornea
Volume15
Issue number2
Publication statusPublished - 1996
Externally publishedYes

Fingerprint

Rose Bengal
Tears
Therapeutics
Epithelial Cells
Staining and Labeling
Methylcellulose
Hyaluronic Acid
Humidity
Fluorescein
Hypromellose Derivatives

Keywords

  • Dry eye
  • Hydroxypropyl methylcellulose
  • Sjögren's syndrome

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Hydroxypropyl Methylcellulose for the Treatment of Severe Dry Eye Associated with Sjögren's Syndrome. / Toda, Ikuko; Shinozaki, Naoshi; Tsubota, Kazuo.

In: Cornea, Vol. 15, No. 2, 1996, p. 120-128.

Research output: Contribution to journalArticle

@article{ec126ec9021b4ea4bd1034637c25b32b,
title = "Hydroxypropyl Methylcellulose for the Treatment of Severe Dry Eye Associated with Sj{\"o}gren's Syndrome",
abstract = "Our purpose was to evaluate the efficacy of a new formulation of methylcellulose, preservative-free 0.5{\%} hydroxypropyl methylcellulose (HPMC), for the treatment of dry eye. In the clinical part of our study, two groups of dry-eye patients, those with Sj{\"o}gren's syndrome (SS) and those without (non-SS), were treated topically with 0.5{\%} HPMC and evaluated for symptoms, ocular surface vital staining, tear breakup time (BUT), and tear evaporation rate from the ocular surface at 40{\%} ambient humidity (TEROS40). In the in vitro part of the study, rose bengal uptake was measured in human conjunctival epithelial cells, which were cultured and incubated with or without 0.5{\%} HPMC. Although symptoms improved in both groups, rose bengal and fluorescein staining and BUT improved significantly only in the SS group. TEROS40 increased for 30 min after instillation of 0.5{\%} HPMC, but not after the use of 0.1{\%} sodium hyaluronate or saline-based artificial tears. Rose bengal uptake by cultured conjunctival epithelial cells was blocked by 0.5{\%} HPMC. These findings suggest that 0.5{\%} HPMC provides long coverage of and protection for the ocular surface. Patients with severe dry eye, such as in SS, are good candidates for this treatment.",
keywords = "Dry eye, Hydroxypropyl methylcellulose, Sj{\"o}gren's syndrome",
author = "Ikuko Toda and Naoshi Shinozaki and Kazuo Tsubota",
year = "1996",
language = "English",
volume = "15",
pages = "120--128",
journal = "Cornea",
issn = "0277-3740",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Hydroxypropyl Methylcellulose for the Treatment of Severe Dry Eye Associated with Sjögren's Syndrome

AU - Toda, Ikuko

AU - Shinozaki, Naoshi

AU - Tsubota, Kazuo

PY - 1996

Y1 - 1996

N2 - Our purpose was to evaluate the efficacy of a new formulation of methylcellulose, preservative-free 0.5% hydroxypropyl methylcellulose (HPMC), for the treatment of dry eye. In the clinical part of our study, two groups of dry-eye patients, those with Sjögren's syndrome (SS) and those without (non-SS), were treated topically with 0.5% HPMC and evaluated for symptoms, ocular surface vital staining, tear breakup time (BUT), and tear evaporation rate from the ocular surface at 40% ambient humidity (TEROS40). In the in vitro part of the study, rose bengal uptake was measured in human conjunctival epithelial cells, which were cultured and incubated with or without 0.5% HPMC. Although symptoms improved in both groups, rose bengal and fluorescein staining and BUT improved significantly only in the SS group. TEROS40 increased for 30 min after instillation of 0.5% HPMC, but not after the use of 0.1% sodium hyaluronate or saline-based artificial tears. Rose bengal uptake by cultured conjunctival epithelial cells was blocked by 0.5% HPMC. These findings suggest that 0.5% HPMC provides long coverage of and protection for the ocular surface. Patients with severe dry eye, such as in SS, are good candidates for this treatment.

AB - Our purpose was to evaluate the efficacy of a new formulation of methylcellulose, preservative-free 0.5% hydroxypropyl methylcellulose (HPMC), for the treatment of dry eye. In the clinical part of our study, two groups of dry-eye patients, those with Sjögren's syndrome (SS) and those without (non-SS), were treated topically with 0.5% HPMC and evaluated for symptoms, ocular surface vital staining, tear breakup time (BUT), and tear evaporation rate from the ocular surface at 40% ambient humidity (TEROS40). In the in vitro part of the study, rose bengal uptake was measured in human conjunctival epithelial cells, which were cultured and incubated with or without 0.5% HPMC. Although symptoms improved in both groups, rose bengal and fluorescein staining and BUT improved significantly only in the SS group. TEROS40 increased for 30 min after instillation of 0.5% HPMC, but not after the use of 0.1% sodium hyaluronate or saline-based artificial tears. Rose bengal uptake by cultured conjunctival epithelial cells was blocked by 0.5% HPMC. These findings suggest that 0.5% HPMC provides long coverage of and protection for the ocular surface. Patients with severe dry eye, such as in SS, are good candidates for this treatment.

KW - Dry eye

KW - Hydroxypropyl methylcellulose

KW - Sjögren's syndrome

UR - http://www.scopus.com/inward/record.url?scp=0030064968&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030064968&partnerID=8YFLogxK

M3 - Article

C2 - 8925658

AN - SCOPUS:0030064968

VL - 15

SP - 120

EP - 128

JO - Cornea

JF - Cornea

SN - 0277-3740

IS - 2

ER -